Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-25 @ 7:34 PM
NCT ID: NCT02637232
Description: Analysis was performed on safety population that comprised of subjects included and with at least a post-Baseline visit or information regarding the adverse event.
Frequency Threshold: 2
Time Frame: From Baseline (Day 0) up to study follow-up visit at Week 4 (Day 31).
Study: NCT02637232
Study Brief: Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Mirvaso® / Onreltea TM Mirvaso® / Onreltea TM 0 None 1 259 61 259 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
ANGINA PECTORIS NON_SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (17.0) View
AORTIC ECTASIA NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.0) View
STENOSIS OF ILIACA EXTERNAL NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.0) View
RIVA STENOSIS NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Erythema NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.0) View
Pruritus NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.0) View
Rosacea NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.0) View
Skin burning sensation NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.0) View
Skin irritation NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.0) View
Flushing NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (17.0) View
Skin swelling NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (17.0) View